Insights into the endoscopic management of esophageal achalasia.

IF 3 Q2 GASTROENTEROLOGY & HEPATOLOGY
Therapeutic Advances in Gastrointestinal Endoscopy Pub Date : 2021-05-05 eCollection Date: 2021-01-01 DOI:10.1177/26317745211014706
Elizabeth Brindise, Mouen A Khashab, Rami El Abiad
{"title":"Insights into the endoscopic management of esophageal achalasia.","authors":"Elizabeth Brindise,&nbsp;Mouen A Khashab,&nbsp;Rami El Abiad","doi":"10.1177/26317745211014706","DOIUrl":null,"url":null,"abstract":"<p><p>Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.</p>","PeriodicalId":40947,"journal":{"name":"Therapeutic Advances in Gastrointestinal Endoscopy","volume":"14 ","pages":"26317745211014706"},"PeriodicalIF":3.0000,"publicationDate":"2021-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/26317745211014706","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastrointestinal Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26317745211014706","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.

Abstract Image

Abstract Image

Abstract Image

食管贲门失弛缓症的内镜治疗。
贲门失弛缓症是一种原发性食管运动障碍,其特征是肌肠丛中抑制性神经元的丧失,导致食管胃连接处松弛受损。贲门失弛缓症是一种无法治愈的疾病,治疗方式主要是破坏食管胃交界处,从药理学到内窥镜再到外科手术,治疗方式各不相同。传统的内窥镜治疗包括气动扩张、肉毒杆菌毒素注射和经口内窥镜肌切开术。本文综述了贲门失弛缓症的内镜治疗,并重点介绍了经口内窥镜下肌切开术和其他新方法的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
0.00%
发文量
8
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信